Results 191 to 200 of about 13,908 (226)

Prior immunity to seasonal influenza A(H3N2) virus confers varying levels of cross-protection against challenge with clade 2.3.4.4b A(H5N1), A(H7N9), or A(H9N2) virus in a ferret model. [PDF]

Microbiol Spectr
Sun X, Belser JA, Li Z-N, Liu F, Brock N, Pulit-Penaloza JA, Kieran TJ, Pappas C, Zeng H, Chang JC, Carney PJ, Bradley-Ferrell BL, Stevens J, Levine MZ, Tumpey TM, Maines TR.   +15 more
europepmc   +1 more source

Risk Assessment of the Tropism and Pathogenesis of the Highly Pathogenic Avian Influenza A/H7N9 Virus Using Ex Vivo and In Vitro Cultures of Human Respiratory Tract. [PDF]

J Infect Dis, 2019
Chan LLY, Hui KPY, Kuok DIT, Bui CHT, Ng KC, Mok CKP, Yang ZF, Guan W, Poon LLM, Zhong N, Peiris JSM, Nicholls JM, Chan MCW.   +12 more
europepmc   +1 more source

Evolutionary lineage and host origin influence virulence and mammalian adaptation of H7N9 avian influenza viruses. [PDF]

Poult Sci
Wu W, Liu Y, Zhang J, Zhou J, Wang T, Chang H, Yang Q, Huang X, Yin H, Jia W.   +9 more
europepmc   +1 more source

Evolutionary pathway for the 2017 emergence of a novel highly pathogenic avian influenza A(H7N9) virus among domestic poultry in Tennessee, United States. [PDF]

Virology, 2018
Li L, DeLiberto TJ, Killian ML, Torchetti MK, Wan XF.   +4 more
europepmc   +1 more source

Plant-Produced Broadly Neutralizing Influenza Monoclonal Antibody CR9114 Exhibits Activity Against Heterologous Avian Influenza Viruses. [PDF]

Vaccines (Basel)
Jaratsittisin J, Aung WW, Rattanapisit K, Suwanchaikasem P, Matphong W, Srisutthisamphan K, Wanasen N, Teeravechyan S, Phoolcharoen W.   +8 more
europepmc   +1 more source

Evolutionary Rate Variation at Predicted PTM Sites Reveals Localized Host-Associated Patterns in Influenza A Virus. [PDF]

Genome Biol Evol
Teufel AI, Hasan MI, Smyth DS.
europepmc   +1 more source

Prognostic factors in H7N9 avian influenza: a systematic review based on case reports. [PDF]

BMC Infect Dis
Li F, Song K, Ren X.
europepmc   +1 more source

Aerosol Inhalation of a Recombinant H7N9 Hemagglutinin Antigen Elicits Systemic and Mucosal Immune Responses in Mice. [PDF]

Viruses
Hou Z, Wang H, Zhang B, Liu R, Zhang Y, Yang Y, Wu J, Hou X, Ge X, Wu J, Liu B.   +10 more
europepmc   +1 more source

A CRISPR activation screen identifies CH25H as a restriction factor against influenza viruses by targeting accessible cholesterol. [PDF]

Emerg Microbes Infect
Huang J, Ma K, Ding S, Wang Y, Xiong J, Yi J, Zhang J, He Z, Huang L, Ren X, Zhou J, Chen X, Liu L, Qi W, Wang S, Liao M.   +15 more
europepmc   +1 more source

Nasal RNA-scaffold-protein vaccine protects mice from human H5N1 clade 2.3.4.4b virus lethal infection and safeguards against vaccine-unmatched viruses. [PDF]

EBioMedicine
Lam JY, Yuen CK, Cheung SK, Cheung PH, Yuen KY, Kok KH.   +5 more
europepmc   +1 more source